Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
暂无分享,去创建一个
Jelena Djokić Kovač | J. Kovač | Aleksandra Đurić-Stefanović | D. Mašulović | Danijel Galun | Aleksandra Đurić-Stefanović | Gordana Lilić | Dragan Vasin | Ljubica Lazić | Dragan Mašulović | Đorđije Šaranović | L. Lazić | D. Galun | Dragan Vasin | G. Lilic | Đorđije Šaranović
[1] Hyeon Je Cho,et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[2] R Sinkus,et al. [Diffusion-weighted MR imaging of the liver]. , 2010, Journal de radiologie.
[3] I. Kovalszky,et al. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas. , 2010, Human pathology.
[4] Young Kon Kim,et al. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. , 2009, European journal of radiology.
[5] M. Haider,et al. Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma. , 2009, AJR. American journal of roentgenology.
[6] Myeong-Jin Kim,et al. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. , 2013, AJR. American journal of roentgenology.
[7] I. Okayasu,et al. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: Comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas , 2005, Pathology international.
[8] M. Kanematsu,et al. Spectrum of MRI appearances of untreated metastases of the liver. , 2003, AJR. American journal of roentgenology.
[9] R. Lenzi,et al. The biology of unknown primary tumors. , 1993, Seminars in oncology.
[10] T. Pawlik,et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.
[11] Y. Nakanuma,et al. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver , 2000, Histopathology.
[12] Eun Sun Lee,et al. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging , 2016, European Radiology.
[13] R. Semelka,et al. Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? , 2014, Abdominal Imaging.
[14] Young Kon Kim,et al. Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging: Emphasis on the Differentiation of Intrahepatic Cholangiocarcinoma , 2013, Journal of computer assisted tomography.
[15] Noriyuki Moriyama,et al. Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review , 2013, Abdominal Imaging.
[16] A. Dohan,et al. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging. , 2015, European journal of radiology.
[17] O. Farges,et al. Resection of intrahepatic cholangiocarcinoma: a Western experience. , 1999, Journal of hepato-biliary-pancreatic surgery.
[18] Young Kon Kim,et al. Diagnostic Accuracy and Sensitivity of Diffusion-Weighted and of Gadoxetic Acid-Enhanced 3-T MR Imaging Alone or in Combination in the Detection of Small Liver Metastasis (⩽1.5 cm in Diameter) , 2012, Investigative radiology.
[19] N. Pavlidis,et al. Cancer of unknown primary site , 2012, The Lancet.
[20] J. H. Lim,et al. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. , 2003, AJR. American journal of roentgenology.
[21] J. Konishi,et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. , 2001, AJR. American journal of roentgenology.
[22] H. Kressel,et al. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. , 1991, Radiology.
[23] K. Kumamoto,et al. Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer. , 2011, International surgery.
[24] B. Choi,et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. , 2011, Radiology.
[25] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[26] R. Reznek,et al. Cancer of unknown primary site. , 2008, Clinical medicine.
[27] R. Semelka,et al. Liver metastases from unknown primary site: demonstration on MR images. , 2003, Magnetic resonance imaging.
[28] J. M. Lee,et al. Imaging of intrahepatic and hilar cholangiocarcinoma , 2004, Abdominal Imaging.
[29] D. Bluemke,et al. CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. , 1994, AJR. American journal of roentgenology.
[30] I. Choo,et al. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.
[31] Bachir Taouli,et al. Diffusion-weighted MR imaging for liver lesion characterization: a critical look. , 2012, Radiology.
[32] Young Kon Kim,et al. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma , 2013, Abdominal Imaging.